TY - JOUR
T1 - Tremor rating scales and laboratory tools for assessing tremor
AU - Elble, Rodger J.
AU - Ondo, William
N1 - Funding Information:
Rodger Elble is an employee of SIU Medicine; has served as a consultant for Applied Therapeutics, BridgeBio, Cadent, Cydan, Jazz, Neurocrine Biosciences, Novartis, Osmotica, Praxis Precision Medicines, and Sage; has served on advisory boards for the International Essential Tremor Foundation and the Neuroscience Research Foundation of Kiwanis International, Illinois-Eastern Iowa District; and has received grants from the Neuroscience Research Foundation of Kiwanis International, Illinois-Eastern Iowa District.
Funding Information:
William Ondo has received honoraria for speaking bureau from TEVA, ACADIA, Acorda, ADAMAS, Neurocrine, UCB Pharma, US WorldMeds, and Sunovion. He has received research grants from Biogen, Lundbeck, Sun, Restless Legs Syndrome Foundation, Parkinson Study Group, Sun, Biogen, Cerevel and Revance. Consulting fees: Takeda, Merz, Jazz, XWPharma, Neurocrine, Emalex, Sage, and Cadent. Royalties: from the books Restless Legs Syndrome, Movement Disorders in Clinical Practice, and UpToDate.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/4/15
Y1 - 2022/4/15
N2 - The purpose of this review is to characterize and compare validated clinical rating scales and transducers that are used in the clinical assessment of tremor disorders. Tremor is an involuntary oscillatory movement of a body part. Tremor can be characterized in terms of amplitude and frequency of oscillation, and these kinematic properties vary randomly and with activities of daily living. Clinical rating scales are most useful when performing a comprehensive assessment of tremor severity (amplitude), anatomical distribution, activation conditions, and impact on activities of daily living and quality of life. Motion transducers are often used in conjunction with surface electromyography to discern properties of tremor that are important diagnostically. Motion transducers are needed for an accurate determination of tremor frequency and for precise quantification of changes in amplitude and frequency over time. The precision and accuracy of motion transducers exceed that of all clinical rating scales. However, these advantages of transducers are mitigated by the considerable within-subject random variability in tremor amplitude, such that the smallest detectable statistically significant change in tremor amplitude is comparable for scales and transducers. Comprehensive anatomical and behavioral assessment of tremor with transducers is not clinically feasible. Transducers and scales are presently viewed as complementary methods of quantifying tremor amplitude. Transducer measures are logarithmically related to clinical ratings, as predicted by the Weber-Fechner law of psychophysics. This relationship must be considered when interpreting change in clinical ratings, produced by disease or treatment. This article is part of the Special Issue “Tremor” edited by Daniel D. Truong, Mark Hallett, and Aasef Shaikh.
AB - The purpose of this review is to characterize and compare validated clinical rating scales and transducers that are used in the clinical assessment of tremor disorders. Tremor is an involuntary oscillatory movement of a body part. Tremor can be characterized in terms of amplitude and frequency of oscillation, and these kinematic properties vary randomly and with activities of daily living. Clinical rating scales are most useful when performing a comprehensive assessment of tremor severity (amplitude), anatomical distribution, activation conditions, and impact on activities of daily living and quality of life. Motion transducers are often used in conjunction with surface electromyography to discern properties of tremor that are important diagnostically. Motion transducers are needed for an accurate determination of tremor frequency and for precise quantification of changes in amplitude and frequency over time. The precision and accuracy of motion transducers exceed that of all clinical rating scales. However, these advantages of transducers are mitigated by the considerable within-subject random variability in tremor amplitude, such that the smallest detectable statistically significant change in tremor amplitude is comparable for scales and transducers. Comprehensive anatomical and behavioral assessment of tremor with transducers is not clinically feasible. Transducers and scales are presently viewed as complementary methods of quantifying tremor amplitude. Transducer measures are logarithmically related to clinical ratings, as predicted by the Weber-Fechner law of psychophysics. This relationship must be considered when interpreting change in clinical ratings, produced by disease or treatment. This article is part of the Special Issue “Tremor” edited by Daniel D. Truong, Mark Hallett, and Aasef Shaikh.
KW - Activities of daily living
KW - Psychophysics
KW - Quality of life
KW - Rating scale
KW - Transducers
KW - Tremor
UR - http://www.scopus.com/inward/record.url?scp=85125433294&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125433294&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2022.120202
DO - 10.1016/j.jns.2022.120202
M3 - Review article
C2 - 35220111
AN - SCOPUS:85125433294
VL - 435
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
SN - 0022-510X
M1 - 120202
ER -